BioInvent International AB (publ) Key Executives
This section highlights BioInvent International AB (publ)'s key executives, including their titles and compensation details.
Find Contacts at BioInvent International AB (publ)
(Showing 0 of )
BioInvent International AB (publ) Earnings
This section highlights BioInvent International AB (publ)'s earnings, including key dates, EPS, earnings reports, and earnings call transcripts.
Next Earnings Date
Last Earnings Results
Earnings Call Transcripts
Transcript | Quarter | Year | Date | Estimated EPS | Actual EPS |
---|

BioInvent International AB (publ), a clinical-stage company, discovers, researches, and develops immuno-modulatory antibodies for the treatment of cancer in Sweden, Europe, the United States, Japan, and internationally. Its lead drug candidate is BI-1206 for the treatment of non-Hodgkin lymphoma and solid tumors. The company also develops tumor associated myeloid cells; cancer-associated regulatory T cells, which modulate the immune system; BT-001 in solid tumors; and BI-1808 and BI-1910, which are anti-TNFR2 antibodies for the treatment of solid tumors and cutaneous T-cell lymphoma. It has a strategic collaboration with Pfizer Inc. for the development of antibodies against tumor-associated myeloid cells; partnership and collaboration with Transgene to co-develskylinop multi-functional oncolytic viruses for treatment of solid tumors; and collaboration and supply agreement with Merck for the clinical development of BI-1808. The Company was incorporated in 1996 and is based in Lund, Sweden.
$31.65
Stock Price
$2.08B
Market Cap
-
Employees
Lund, None
Location
Financial Statements
Access annual & quarterly financial statements for BioInvent International AB (publ), including income statements, balance sheets, and cash flow statements..
Annual Income Statement
Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
---|---|---|---|---|---|
Revenue | $44.69M | $71.46M | $326.13M | $19.38M | $147.37M |
Cost of Revenue | $- | $- | $- | $- | $- |
Gross Profit | $44.69M | $71.46M | $326.13M | $19.38M | $147.37M |
Gross Profit Ratio | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Research and Development Expenses | $457.73M | $390.43M | $325.93M | $258.34M | $191.42M |
General and Administrative Expenses | $58.30M | $51.61M | $50.75M | $39.44M | $32.16M |
Selling and Marketing Expenses | $- | $- | $- | $- | $31.64M |
Selling General and Administrative Expenses | $58.30M | $51.61M | $50.75M | $39.44M | $31.64M |
Other Expenses | $-290.00K | $-637.00K | $-81.00K | $-226.00K | $-731.00K |
Operating Expenses | $515.75M | $441.40M | $376.60M | $297.55M | $222.33M |
Cost and Expenses | $515.75M | $441.40M | $376.60M | $297.55M | $222.33M |
Interest Income | $- | $40.60M | $9.07M | $264.00K | $28.00K |
Interest Expense | $- | $638.00K | $650.00K | $517.00K | $336.00K |
Depreciation and Amortization | $19.30M | $16.75M | $14.72M | $14.61M | $12.00M |
EBITDA | $-451.76M | $-312.71M | $-27.13M | $-263.32M | $-63.99M |
EBITDA Ratio | -1010.96% | -437.59% | -8.32% | -1358.42% | -43.42% |
Operating Income | $-471.06M | $-369.94M | $-50.92M | $-278.35M | $-75.47M |
Operating Income Ratio | -1054.15% | -517.68% | -15.61% | -1435.98% | -51.21% |
Total Other Income Expenses Net | $41.82M | $39.84M | $8.42M | $-94.00K | $-859.00K |
Income Before Tax | $-429.24M | $-330.10M | $-42.50M | $-278.44M | $-76.33M |
Income Before Tax Ratio | -960.57% | -461.93% | -13.03% | -1436.46% | -51.80% |
Income Tax Expense | $135.00K | $204.00K | $-8.42M | $517.00K | $336.00K |
Net Income | $-429.38M | $-330.30M | $-34.09M | $-278.96M | $-76.67M |
Net Income Ratio | -960.87% | -462.22% | -10.45% | -1439.13% | -52.02% |
EPS | $-6.54 | $-5.02 | $-0.55 | $-5.15 | $-2.67 |
EPS Diluted | $-6.54 | $-5.02 | $-0.55 | $-5.15 | $-2.67 |
Weighted Average Shares Outstanding | 65.68M | 65.80M | 61.52M | 54.16M | 28.72M |
Weighted Average Shares Outstanding Diluted | 65.68M | 65.80M | 61.52M | 54.16M | 28.72M |
SEC Filing | Source | Source | Source | Source | Source |
Breakdown | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | $21.37M | $12.76M | $4.61M | $5.94M | $15.32M | $26.80M | $13.10M | $16.25M | $20.64M | $17.92M | $270.91M | $16.66M | $4.90M | $2.99M | $5.29M | $6.20M | $98.74M | $16.27M | $15.65M | $16.71M |
Cost of Revenue | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Gross Profit | $21.37M | $12.76M | $4.61M | $5.94M | $15.32M | $26.80M | $13.10M | $16.25M | $20.64M | $17.92M | $270.91M | $16.66M | $4.90M | $2.99M | $5.29M | $6.20M | $98.74M | $16.27M | $15.65M | $16.71M |
Gross Profit Ratio | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Research and Development Expenses | $129.29M | $107.47M | $138.59M | $82.38M | $111.60M | $96.88M | $97.65M | $84.46M | $84.98M | $77.67M | $91.40M | $71.87M | $70.45M | $57.64M | $53.67M | $76.58M | $60.08M | $41.30M | $47.62M | $42.43M |
General and Administrative Expenses | $17.70M | $12.82M | $14.48M | $13.30M | $15.10M | $11.28M | $12.78M | $12.42M | $15.23M | $10.43M | $11.92M | $13.17M | $11.96M | $7.82M | $10.19M | $9.47M | $- | $7.47M | $7.43M | $7.80M |
Selling and Marketing Expenses | $- | $- | $-4.88M | $-4.71M | $-4.52M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Selling General and Administrative Expenses | $17.70M | $12.82M | $9.60M | $8.59M | $10.58M | $11.28M | $12.78M | $12.42M | $15.23M | $10.43M | $11.92M | $13.17M | $11.96M | $7.82M | $10.19M | $9.47M | $8.94M | $7.47M | $7.43M | $7.80M |
Other Expenses | $251.00K | $-375.00K | $-141.00K | $- | $- | $- | $- | $310.00K | $-757.00K | $-1.03M | $1.80M | $-91.00K | $1.16M | $-38.00K | $-1.46M | $117.00K | $-199.00K | $317.00K | $-305.00K | $-544.00K |
Operating Expenses | $147.24M | $119.91M | $148.19M | $90.97M | $122.17M | $108.28M | $109.85M | $97.19M | $99.45M | $87.07M | $105.12M | $84.95M | $83.56M | $65.42M | $62.40M | $86.17M | $68.82M | $49.08M | $54.75M | $49.69M |
Cost and Expenses | $147.24M | $119.91M | $153.07M | $95.69M | $126.73M | $108.28M | $109.85M | $97.19M | $99.45M | $87.07M | $105.12M | $84.95M | $83.56M | $65.42M | $62.40M | $86.17M | $68.82M | $49.08M | $54.75M | $49.69M |
Interest Income | $- | $9.93M | $- | $11.80M | $13.97M | $10.25M | $8.40M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Interest Expense | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Depreciation and Amortization | $4.88M | $4.83M | $4.88M | $4.71M | $4.56M | $4.24M | $4.10M | $3.86M | $4.02M | $3.65M | $3.58M | $3.48M | $3.68M | $3.88M | $3.57M | $3.48M | $3.11M | $3.07M | $3.00M | $2.83M |
EBITDA | $-121.00M | $-102.31M | $-143.44M | $-85.01M | $-92.39M | $-77.08M | $-92.66M | $-77.08M | $-74.32M | $-65.51M | $169.37M | $-64.81M | $-74.74M | $-58.55M | $-53.54M | $-76.49M | $33.03M | $-29.74M | $-36.10M | $-30.14M |
EBITDA Ratio | -566.23% | -801.58% | -3113.88% | -1431.05% | -697.53% | -327.06% | -771.74% | -518.73% | -320.62% | -395.03% | 61.90% | -392.30% | -1524.39% | -1950.35% | -1008.96% | -1236.56% | 32.40% | -182.44% | -229.20% | -182.32% |
Operating Income | $-125.87M | $-107.15M | $-148.46M | $-89.74M | $-111.41M | $-81.48M | $-96.75M | $-80.94M | $-79.26M | $-69.15M | $165.55M | $-68.29M | $-78.85M | $-62.43M | $-57.11M | $-79.97M | $29.41M | $-32.81M | $-39.10M | $-32.97M |
Operating Income Ratio | -589.04% | -839.44% | -3219.74% | -1510.33% | -727.29% | -304.06% | -738.85% | -498.12% | -384.03% | -385.89% | 61.11% | -409.92% | -1608.14% | -2085.87% | -1079.95% | -1289.76% | 29.78% | -201.72% | -249.86% | -197.27% |
Total Other Income Expenses Net | $9.04M | $9.93M | $11.04M | $11.80M | $13.97M | $10.25M | $8.40M | $7.21M | $928.00K | $5.52M | $1.90M | $540.00K | $87.00K | $-175.00K | $-183.00K | $177.00K | $-888.00K | $-63.00K | $-237.00K | $329.00K |
Income Before Tax | $-116.83M | $-97.21M | $-137.28M | $-77.92M | $-96.95M | $-71.08M | $-88.35M | $-73.73M | $-78.33M | $-63.87M | $167.45M | $-67.75M | $-78.76M | $-62.60M | $-57.29M | $-79.79M | $28.52M | $-32.88M | $-39.34M | $-32.64M |
Income Before Tax Ratio | -546.74% | -761.63% | -2977.21% | -1311.26% | -632.91% | -265.26% | -674.66% | -453.74% | -379.53% | -356.41% | 61.81% | -406.68% | -1606.36% | -2091.71% | -1083.42% | -1286.90% | 28.88% | -202.10% | -251.37% | -195.30% |
Income Tax Expense | $48.00K | $28.00K | $28.00K | $31.00K | $204.00K | $-10.40M | $-8.40M | $-14.42M | $8.14M | $-5.28M | $-1.90M | $-540.00K | $423.00K | $175.00K | $183.00K | $-177.00K | $-1.04M | $63.00K | $237.00K | $-329.00K |
Net Income | $-116.88M | $-97.24M | $-137.31M | $-77.95M | $-97.16M | $-71.08M | $-88.35M | $-59.31M | $-86.47M | $-58.58M | $167.45M | $-67.21M | $-78.76M | $-62.60M | $-57.29M | $-79.79M | $28.52M | $-32.88M | $-39.34M | $-32.64M |
Net Income Ratio | -546.96% | -761.85% | -2977.81% | -1311.78% | -634.24% | -265.26% | -674.66% | -364.97% | -418.97% | -326.92% | 61.81% | -403.43% | -1606.36% | -2091.71% | -1083.42% | -1286.90% | 28.88% | -202.10% | -251.37% | -195.30% |
EPS | $-1.78 | $-1.48 | $-2.09 | $-1.18 | $-1.48 | $-1.08 | $-1.34 | $-0.90 | $-1.33 | $-0.92 | $2.86 | $-1.15 | $-1.45 | $-1.07 | $-0.98 | $-1.94 | $0.87 | $-1.00 | $-2.00 | $-1.63 |
EPS Diluted | $-1.78 | $-1.48 | $-2.09 | $-1.18 | $-1.48 | $-1.08 | $-1.34 | $-0.90 | $-1.33 | $-0.92 | $2.86 | $-1.15 | $-1.45 | $-1.07 | $-0.98 | $-1.94 | $0.87 | $-1.00 | $-2.00 | $-1.63 |
Weighted Average Shares Outstanding | 65.66M | 65.70M | 65.80M | 65.80M | 65.80M | 65.80M | 65.80M | 65.80M | 64.97M | 63.87M | 58.47M | 58.40M | 54.16M | 58.47M | 58.46M | 41.13M | 32.88M | 32.88M | 19.67M | 20.03M |
Weighted Average Shares Outstanding Diluted | 65.66M | 65.70M | 65.80M | 65.80M | 65.80M | 65.80M | 65.80M | 65.80M | 64.97M | 63.87M | 58.55M | 58.40M | 54.16M | 58.51M | 58.46M | 41.13M | 32.88M | 32.88M | 19.67M | 20.03M |
SEC Filing | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source |
Annual Balance Sheet
Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
---|---|---|---|---|---|
Cash and Cash Equivalents | $434.83M | $259.55M | $515.05M | $910.75M | $729.27M |
Short Term Investments | $432.33M | $809.15M | $502.43M | $172.07M | $- |
Cash and Short Term Investments | $867.16M | $1.07B | $1.02B | $1.08B | $729.27M |
Net Receivables | $- | $11.93M | $36.58M | $370.00K | $29.92M |
Inventory | $10.97M | $11.84M | $11.51M | $16.85M | $4.08M |
Other Current Assets | $65.09M | $40.79M | $42.69M | $15.97M | $9.78M |
Total Current Assets | $943.21M | $1.13B | $1.08B | $1.12B | $773.04M |
Property Plant Equipment Net | $46.02M | $52.66M | $52.01M | $49.08M | $29.60M |
Goodwill | $- | $- | $- | $- | $- |
Intangible Assets | $- | $- | $- | $- | $- |
Goodwill and Intangible Assets | $- | $- | $- | $- | $- |
Long Term Investments | $- | $-594.90M | $73.71M | $110.13M | $580.00K |
Tax Assets | $- | $- | $- | $- | $- |
Other Non-Current Assets | $- | $809.15M | $502.43M | $172.07M | $-580.00K |
Total Non-Current Assets | $46.02M | $266.92M | $628.15M | $331.29M | $29.60M |
Other Assets | $- | $- | $- | $- | $- |
Total Assets | $989.24M | $1.40B | $1.71B | $1.45B | $802.64M |
Account Payables | $- | $29.19M | $41.35M | $19.72M | $16.91M |
Short Term Debt | $9.20M | $8.71M | $8.19M | $-16.37M | $-16.64M |
Tax Payables | $- | $- | $- | $- | $- |
Deferred Revenue | $- | $- | $- | $23.20M | $22.61M |
Other Current Liabilities | $86.01M | $38.02M | $37.78M | $9.04M | $8.02M |
Total Current Liabilities | $95.21M | $75.92M | $87.32M | $58.79M | $53.51M |
Long Term Debt | $8.21M | $14.54M | $18.77M | $21.53M | $5.63M |
Deferred Revenue Non-Current | $- | $- | $- | $- | $- |
Deferred Tax Liabilities Non-Current | $- | $- | $- | $- | $- |
Other Non-Current Liabilities | $- | $- | $- | $- | $- |
Total Non-Current Liabilities | $8.21M | $14.54M | $18.77M | $21.53M | $5.63M |
Other Liabilities | $- | $- | $- | $- | $- |
Total Liabilities | $103.42M | $90.45M | $106.09M | $80.32M | $59.14M |
Preferred Stock | $- | $- | $- | $- | $- |
Common Stock | $- | $13.16M | $12.99M | $11.69M | $78.75M |
Retained Earnings | $- | $-2.46B | $-2.14B | $-2.09B | $-1.82B |
Accumulated Other Comprehensive Income Loss | $- | $1.00K | $1.00K | $1.00K | $1.00K |
Other Total Stockholders Equity | $885.82M | $3.76B | $3.73B | $3.45B | $2.48B |
Total Stockholders Equity | $885.82M | $1.31B | $1.61B | $1.37B | $743.50M |
Total Equity | $885.82M | $1.31B | $1.61B | $1.37B | $743.50M |
Total Liabilities and Stockholders Equity | $989.24M | $1.40B | $1.71B | $1.45B | $802.64M |
Minority Interest | $- | $- | $- | $- | $- |
Total Liabilities and Total Equity | $989.24M | $1.40B | $1.71B | $1.45B | $802.64M |
Total Investments | $432.33M | $214.25M | $576.14M | $282.21M | $580.00K |
Total Debt | $17.41M | $23.24M | $26.96M | $28.37M | $11.60M |
Net Debt | $-417.41M | $-236.30M | $-488.08M | $-882.39M | $-717.67M |
Balance Sheet Charts
Breakdown | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash and Cash Equivalents | $434.83M | $717.36M | $470.25M | $469.14M | $259.55M | $589.79M | $570.57M | $542.52M | $515.05M | $696.32M | $591.22M | $769.79M | $910.75M | $1.26B | $1.51B | $1.58B | $729.27M | $642.10M | $182.28M | $117.13M |
Short Term Investments | $432.33M | $232.75M | $591.25M | $594.96M | $809.15M | $563.95M | $530.60M | $475.96M | $502.43M | $527.05M | $386.81M | $236.95M | $172.07M | $6.00M | $- | $- | $- | $- | $- | $- |
Cash and Short Term Investments | $867.16M | $950.11M | $1.06B | $1.06B | $1.07B | $1.15B | $1.10B | $1.02B | $1.02B | $1.22B | $978.04M | $1.01B | $1.08B | $1.26B | $1.51B | $1.58B | $729.27M | $642.10M | $182.28M | $117.13M |
Net Receivables | $- | $50.98M | $47.95M | $50.26M | $32.66M | $61.84M | $74.48M | $44.69M | $36.58M | $34.95M | $283.02M | $38.00M | $16.34M | $10.08M | $16.03M | $14.39M | $29.92M | $28.04M | $32.39M | $40.20M |
Inventory | $10.97M | $9.89M | $10.52M | $8.98M | $11.84M | $13.31M | $10.75M | $14.12M | $11.51M | $11.24M | $12.17M | $13.48M | $16.85M | $13.13M | $12.45M | $6.89M | $4.08M | $4.21M | $5.57M | $5.81M |
Other Current Assets | $65.09M | $- | $1 | $- | $40.79M | $- | $- | $- | $42.69M | $- | $- | $- | $15.97M | $- | $- | $- | $9.78M | $- | $- | $- |
Total Current Assets | $943.21M | $1.01B | $1.12B | $1.12B | $1.13B | $1.23B | $1.19B | $1.08B | $1.08B | $1.27B | $1.27B | $1.06B | $1.12B | $1.28B | $1.54B | $1.60B | $773.04M | $674.35M | $220.25M | $163.14M |
Property Plant Equipment Net | $46.02M | $47.42M | $50.28M | $50.24M | $52.66M | $50.37M | $51.85M | $51.27M | $52.01M | $44.58M | $46.97M | $48.40M | $49.08M | $51.65M | $50.06M | $28.15M | $29.60M | $29.19M | $30.57M | $31.19M |
Goodwill | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Intangible Assets | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Goodwill and Intangible Assets | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Long Term Investments | $- | $29.07M | $28.75M | $155.05M | $214.25M | $-360.18M | $-170.11M | $51.95M | $73.71M | $-86.08M | $-150.27M | $37.17M | $110.13M | $188.80M | $- | $- | $- | $- | $- | $- |
Tax Assets | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Other Non-Current Assets | $- | $- | $-1 | $-1 | $-1 | $563.95M | $530.60M | $475.96M | $502.43M | $527.05M | $386.81M | $236.95M | $172.07M | $- | $- | $- | $- | $- | $- | $- |
Total Non-Current Assets | $46.02M | $76.49M | $79.02M | $205.29M | $266.91M | $254.14M | $412.34M | $579.18M | $628.15M | $485.55M | $283.51M | $322.52M | $331.29M | $240.45M | $50.06M | $28.15M | $29.60M | $29.19M | $30.57M | $31.19M |
Other Assets | $- | $- | $1 | $1 | $1 | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Total Assets | $989.24M | $1.09B | $1.20B | $1.33B | $1.40B | $1.48B | $1.60B | $1.66B | $1.71B | $1.76B | $1.56B | $1.38B | $1.45B | $1.52B | $1.59B | $1.63B | $802.64M | $703.54M | $250.82M | $194.34M |
Account Payables | $- | $67.36M | $82.37M | $74.81M | $29.19M | $55.58M | $99.27M | $67.56M | $41.35M | $47.26M | $64.18M | $54.68M | $19.72M | $44.74M | $48.76M | $51.12M | $16.91M | $- | $- | $- |
Short Term Debt | $9.20M | $8.71M | $8.71M | $8.71M | $8.71M | $7.74M | $7.97M | $8.19M | $8.19M | $6.52M | $6.63M | $6.73M | $-48.60M | $6.94M | $6.18M | $6.18M | $-47.26M | $6.06M | $6.06M | $6.06M |
Tax Payables | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Deferred Revenue | $- | $- | $-82.37M | $-74.81M | $-5.77M | $-55.58M | $-99.27M | $-67.56M | $- | $-47.26M | $-64.18M | $-54.68M | $23.20M | $-44.74M | $-48.76M | $-51.12M | $22.61M | $- | $- | $- |
Other Current Liabilities | $86.01M | $- | $- | $- | $38.02M | $- | $- | $- | $37.78M | $- | $- | $- | $9.04M | $- | $- | $- | $8.02M | $38.56M | $44.77M | $43.79M |
Total Current Liabilities | $95.21M | $76.06M | $91.08M | $83.52M | $75.92M | $63.32M | $107.24M | $75.75M | $87.32M | $53.78M | $70.81M | $61.41M | $58.79M | $51.68M | $54.95M | $57.31M | $53.51M | $44.62M | $50.82M | $49.85M |
Long Term Debt | $8.21M | $8.31M | $10.40M | $12.47M | $14.54M | $13.46M | $15.17M | $16.86M | $18.77M | $17.06M | $18.56M | $20.05M | $21.53M | $23.00M | $25.14M | $3.98M | $5.63M | $5.12M | $6.58M | $8.03M |
Deferred Revenue Non-Current | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Deferred Tax Liabilities Non-Current | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Other Non-Current Liabilities | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Total Non-Current Liabilities | $8.21M | $8.31M | $10.40M | $12.47M | $14.53M | $13.46M | $15.17M | $16.86M | $18.77M | $17.06M | $18.56M | $20.05M | $21.53M | $23.00M | $25.14M | $3.98M | $5.63M | $5.12M | $6.58M | $8.03M |
Other Liabilities | $- | $- | $- | $1 | $1 | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Total Liabilities | $103.42M | $84.38M | $101.48M | $95.99M | $90.45M | $76.77M | $122.41M | $92.61M | $106.09M | $70.84M | $89.37M | $81.46M | $80.32M | $74.69M | $80.08M | $61.29M | $59.14M | $49.74M | $57.40M | $57.88M |
Preferred Stock | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Common Stock | $- | $13.20M | $13.20M | $13.20M | $13.16M | $13.20M | $13.20M | $13.20M | $12.99M | $13.00M | $11.70M | $11.70M | $11.69M | $11.70M | $11.70M | $11.70M | $78.75M | $653.80M | $193.42M | $136.46M |
Retained Earnings | $- | $- | $- | $- | $-2.46B | $- | $- | $- | $-2.14B | $- | $- | $- | $-2.09B | $- | $- | $- | $-1.82B | $- | $- | $- |
Accumulated Other Comprehensive Income Loss | $- | $- | $1.08B | $1.22B | $1.00K | $1.39B | $1.46B | $1.55B | $1.00K | $- | $- | $1.29B | $1.00K | $- | $- | $- | $1,000 | $- | $- | $- |
Other Total Stockholders Equity | $885.82M | $989.89M | $1.08B | $1.22B | $3.76B | $1.39B | $1.46B | $1.55B | $3.73B | $- | $- | $1.29B | $3.45B | $- | $- | $- | $2.48B | $- | $- | $- |
Total Stockholders Equity | $885.82M | $1.00B | $1.10B | $1.23B | $1.31B | $1.41B | $1.48B | $1.56B | $1.61B | $1.68B | $1.47B | $1.30B | $1.37B | $1.45B | $1.51B | $1.57B | $743.50M | $653.80M | $193.42M | $136.46M |
Total Equity | $885.82M | $1.00B | $1.10B | $1.23B | $1.31B | $1.41B | $1.48B | $1.56B | $1.61B | $1.68B | $1.47B | $1.30B | $1.37B | $1.45B | $1.51B | $1.57B | $743.50M | $653.80M | $193.42M | $136.46M |
Total Liabilities and Stockholders Equity | $989.24M | $1.09B | $1.20B | $1.33B | $1.40B | $1.48B | $1.60B | $1.66B | $1.71B | $1.76B | $1.56B | $1.38B | $1.45B | $1.52B | $1.59B | $1.63B | $802.64M | $703.54M | $250.82M | $194.34M |
Minority Interest | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Total Liabilities and Total Equity | $989.24M | $1.09B | $1.20B | $1.33B | $1.40B | $1.48B | $1.60B | $1.66B | $1.71B | $1.76B | $1.56B | $1.38B | $1.45B | $1.52B | $1.59B | $1.63B | $802.64M | $703.54M | $250.82M | $194.34M |
Total Investments | $432.33M | $261.82M | $620.00M | $750.01M | $214.25M | $203.78M | $360.49M | $527.90M | $576.14M | $440.97M | $236.54M | $274.12M | $282.21M | $188.80M | $- | $- | $- | $- | $- | $- |
Total Debt | $17.41M | $17.02M | $19.11M | $21.18M | $23.24M | $21.20M | $23.13M | $25.05M | $26.96M | $23.58M | $25.18M | $26.78M | $28.37M | $29.94M | $31.32M | $10.17M | $11.60M | $11.18M | $12.64M | $14.09M |
Net Debt | $-417.41M | $-700.34M | $-451.14M | $-447.96M | $-236.30M | $-568.60M | $-547.43M | $-517.46M | $-488.08M | $-672.74M | $-566.04M | $-743.01M | $-882.39M | $-1.23B | $-1.48B | $-1.57B | $-717.67M | $-630.92M | $-169.65M | $-103.04M |
Annual Cash Flow
Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
---|---|---|---|---|---|
Net Income | $-471.06M | $-330.30M | $-50.92M | $-278.35M | $-75.47M |
Depreciation and Amortization | $19.30M | $16.75M | $14.72M | $14.61M | $12.00M |
Deferred Income Tax | $- | $-36.46M | $-1.79M | $-1.14M | $41.00K |
Stock Based Compensation | $5.46M | $2.95M | $1.79M | $1.14M | $-41.00K |
Change in Working Capital | $7.57M | $-10.14M | $-6.78M | $17.03M | $1.20M |
Accounts Receivables | $- | $2.35M | $-38.73M | $23.35M | $-5.94M |
Inventory | $- | $-338.00K | $5.34M | $-12.77M | $1.30M |
Accounts Payables | $- | $-12.16M | $26.62M | $6.44M | $5.84M |
Other Working Capital | $7.57M | $- | $26.62M | $6.44M | $5.84M |
Other Non Cash Items | $58.26M | $15.51M | $1.75M | $869.00K | $-348.00K |
Net Cash Provided by Operating Activities | $-380.47M | $-341.69M | $-41.23M | $-245.84M | $-62.62M |
Investments in Property Plant and Equipment | $-10.03M | $-13.30M | $-12.38M | $-13.26M | $-6.70M |
Acquisitions Net | $- | $- | $- | $- | $- |
Purchases of Investments | $- | $- | $-616.47M | $-454.28M | $- |
Sales Maturities of Investments | $- | $72.98M | $- | $- | $- |
Other Investing Activities | $574.38M | $- | $-616.47M | $-454.28M | $- |
Net Cash Used for Investing Activities | $564.35M | $59.68M | $-628.85M | $-467.54M | $-6.70M |
Debt Repayment | $- | $- | $- | $- | $- |
Common Stock Issued | $- | $30.96M | $279.85M | $900.79M | $650.44M |
Common Stock Repurchased | $- | $- | $- | $- | $- |
Dividends Paid | $- | $- | $- | $- | $- |
Other Financing Activities | $-8.46M | $-7.82M | $-6.36M | $-5.92M | $-5.82M |
Net Cash Used Provided by Financing Activities | $-8.46M | $23.14M | $273.49M | $894.87M | $644.62M |
Effect of Forex Changes on Cash | $- | $3.37M | $880.00K | $- | $- |
Net Change in Cash | $175.28M | $-255.50M | $-395.71M | $181.49M | $575.29M |
Cash at End of Period | $434.83M | $259.55M | $515.05M | $910.75M | $729.27M |
Cash at Beginning of Period | $259.55M | $515.05M | $910.75M | $729.27M | $153.97M |
Operating Cash Flow | $-380.47M | $-341.69M | $-41.23M | $-245.84M | $-62.62M |
Capital Expenditure | $-10.03M | $-13.30M | $-12.38M | $-13.26M | $-6.70M |
Free Cash Flow | $-390.50M | $-355.00M | $-53.60M | $-259.10M | $-69.32M |
Cash Flow Charts
Breakdown | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | $-125.87M | $-97.24M | $-137.31M | $-77.95M | $-97.16M | $-81.32M | $-96.75M | $-80.94M | $-79.26M | $-69.15M | $165.78M | $-68.29M | $-78.85M | $-62.43M | $-57.11M | $-79.97M | $29.41M | $-32.81M | $-39.10M | $-32.97M |
Depreciation and Amortization | $4.88M | $4.83M | $4.88M | $4.71M | $4.56M | $4.24M | $4.10M | $3.86M | $4.02M | $3.65M | $3.58M | $3.48M | $3.68M | $3.88M | $3.57M | $3.48M | $3.11M | $3.07M | $3.00M | $2.83M |
Deferred Income Tax | $- | $- | $- | $- | $-9.74M | $- | $-831.00K | $-496.00K | $-198.00K | $-904.00K | $-639.00K | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Stock Based Compensation | $-398.00K | $- | $2.19M | $856.00K | $617.00K | $1.01M | $831.00K | $496.00K | $198.00K | $904.00K | $639.00K | $48.00K | $252.00K | $-18.00K | $186.00K | $718.00K | $125.00K | $96.00K | $76.00K | $-338.00K |
Change in Working Capital | $3.60M | $-17.51M | $8.38M | $13.10M | $22.35M | $-33.75M | $5.02M | $-3.77M | $2.99M | $237.49M | $-232.40M | $-14.86M | $-711.00K | $1.09M | $-9.67M | $26.32M | $-3.34M | $-1.70M | $10.04M | $-3.81M |
Accounts Receivables | $- | $- | $- | $- | $2.35M | $- | $- | $- | $-38.73M | $- | $- | $- | $23.35M | $- | $- | $- | $-5.94M | $- | $- | $- |
Inventory | $- | $- | $- | $- | $-338.00K | $- | $- | $- | $5.34M | $- | $- | $- | $-12.77M | $- | $- | $- | $1.30M | $- | $- | $- |
Accounts Payables | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Other Working Capital | $3.60M | $-17.51M | $8.38M | $13.10M | $20.34M | $-33.75M | $5.02M | $-3.77M | $36.38M | $237.49M | $-232.40M | $-14.86M | $-11.29M | $1.09M | $-9.67M | $26.32M | $1.31M | $-1.70M | $10.04M | $-3.81M |
Other Non Cash Items | $19.48M | $12.87M | $14.60M | $3.66M | $6.98M | $3.58M | $3.50M | $1.92M | $590.00K | $783.00K | $500.00K | $-128.00K | $137.00K | $-36.00K | $122.00K | $646.00K | $20.00K | $80.00K | $-13.00K | $-435.00K |
Net Cash Provided by Operating Activities | $-98.31M | $-97.05M | $-119.21M | $-65.90M | $-72.39M | $-106.24M | $-84.13M | $-78.92M | $-71.67M | $172.77M | $-62.54M | $-79.80M | $-75.74M | $-57.49M | $-63.09M | $-49.52M | $29.20M | $-31.36M | $-26.08M | $-34.39M |
Investments in Property Plant and Equipment | $-849.00K | $-1.98M | $-4.92M | $-2.28M | $-2.75M | $-2.75M | $-4.68M | $-3.12M | $-6.18M | $-1.25M | $-2.15M | $-2.79M | $-2.97M | $-5.47M | $-2.82M | $-2.00M | $-1.61M | $-1.70M | $-2.37M | $-1.02M |
Acquisitions Net | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Purchases of Investments | $- | $- | $- | $- | $- | $- | $- | $- | $-102.73M | $-344.67M | $-112.28M | $-56.79M | $-265.48M | $-188.80M | $- | $- | $- | $- | $- | $- |
Sales Maturities of Investments | $- | $- | $121.34M | $272.52M | $-250.89M | $126.61M | $118.96M | $78.31M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Other Investing Activities | $-170.46M | $350.97M | $121.34M | $272.52M | $-250.89M | $126.61M | $118.96M | $78.31M | $-102.73M | $-344.67M | $-112.28M | $-56.79M | $-265.48M | $-188.80M | $- | $- | $- | $- | $- | $- |
Net Cash Used for Investing Activities | $-171.30M | $349.00M | $116.42M | $270.24M | $-253.65M | $123.86M | $114.29M | $75.18M | $-108.91M | $-345.92M | $-114.44M | $-59.58M | $-268.45M | $-194.28M | $-2.82M | $-2.00M | $-1.61M | $-1.70M | $-2.37M | $-1.02M |
Debt Repayment | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Common Stock Issued | $- | $- | $- | $- | $- | $- | $- | $30.96M | $- | $279.85M | $- | $- | $- | $- | $- | $900.79M | $61.05M | $494.33M | $95.06M | $- |
Common Stock Repurchased | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Dividends Paid | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Other Financing Activities | $-2.23M | $-2.09M | $-2.07M | $-2.06M | $-2.06M | $-1.93M | $-1.92M | $-1.91M | $-1.57M | $-1.61M | $-1.60M | $-1.59M | $-1.58M | $-1.38M | $-1.51M | $-1.47M | $-1.47M | $-1.46M | $-1.45M | $-1.44M |
Net Cash Used Provided by Financing Activities | $-2.23M | $-2.09M | $-2.07M | $-2.06M | $-2.06M | $-1.93M | $-1.92M | $29.05M | $-1.57M | $278.24M | $-1.60M | $-1.59M | $-1.58M | $-1.38M | $-1.51M | $899.33M | $59.59M | $492.87M | $93.61M | $-1.44M |
Effect of Forex Changes on Cash | $- | $- | $- | $- | $-2.15M | $3.55M | $-182.00K | $2.16M | $880.00K | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Net Change in Cash | $-282.54M | $247.11M | $1.11M | $209.59M | $-330.25M | $19.23M | $28.05M | $27.47M | $-181.27M | $105.09M | $-178.57M | $-140.96M | $-345.76M | $-253.15M | $-67.42M | $847.81M | $87.17M | $459.81M | $65.16M | $-36.85M |
Cash at End of Period | $434.83M | $717.36M | $470.25M | $469.14M | $259.55M | $589.79M | $570.57M | $542.52M | $515.05M | $696.32M | $591.22M | $769.79M | $910.75M | $1.26B | $1.51B | $1.58B | $729.27M | $642.10M | $182.28M | $117.13M |
Cash at Beginning of Period | $717.36M | $470.25M | $469.14M | $259.55M | $589.79M | $570.57M | $542.52M | $515.05M | $696.32M | $591.22M | $769.79M | $910.75M | $1.26B | $1.51B | $1.58B | $729.27M | $642.10M | $182.28M | $117.13M | $153.97M |
Operating Cash Flow | $-98.31M | $-97.05M | $-119.21M | $-65.90M | $-72.39M | $-106.24M | $-84.13M | $-78.92M | $-71.67M | $172.77M | $-62.54M | $-79.80M | $-75.74M | $-57.49M | $-63.09M | $-49.52M | $29.20M | $-31.36M | $-26.08M | $-34.39M |
Capital Expenditure | $-849.00K | $-1.98M | $-4.92M | $-2.28M | $-2.75M | $-2.75M | $-4.68M | $-3.12M | $-6.18M | $-1.25M | $-2.15M | $-2.79M | $-2.97M | $-5.47M | $-2.82M | $-2.00M | $-1.61M | $-1.70M | $-2.37M | $-1.02M |
Free Cash Flow | $-99.16M | $-99.03M | $-124.13M | $-68.18M | $-75.14M | $-108.99M | $-88.81M | $-82.05M | $-77.84M | $171.52M | $-64.69M | $-82.59M | $-78.70M | $-62.97M | $-65.91M | $-51.52M | $27.59M | $-33.05M | $-28.45M | $-35.41M |
BioInvent International AB (publ) Dividends
Explore BioInvent International AB (publ)'s dividend history, including dividend yield, payout ratio, and historical payments.
BioInvent International AB (publ) News
Read the latest news about BioInvent International AB (publ), including recent articles, headlines, and updates.
Similar Companies
Related Metrics
Explore detailed financial metrics and analysis for BINV.ST.